Open AccessEvaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis
Author(s) -
Matteo Risaliti,
Ilenia Bartolini,
Claudia Campani,
Umberto Arena,
Carlotta Xodo,
Valentina Adotti,
Martina Rosi,
Antonio Taddei,
Paolo Muiesan,
Amedeo Amedei,
Giacomo Batignani,
Fabio Marra
Publication year - 2022
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v28.i29.3981
Subject(s) - medicine , hepatocellular carcinoma , propensity score matching , transcatheter arterial chemoembolization , cirrhosis , stage (stratigraphy) , gastroenterology , log rank test , liver cancer , survival analysis , carcinoma , surgery , paleontology , biology
Hepatocellular carcinoma (HCC) is a common tumour often diagnosed with a multifocal presentation. Patients with multifocal HCC represent a heterogeneous group. Although Trans-Arterial ChemoEmbolization (TACE) is the most frequently employed treatment for these patients, previous data suggested that liver resection (LR) could be a safe and effective procedure.